Biologika in der Schwangerschaft

Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.

Zur Anmeldung

AutorIn: ao. Univ.-Prof. Dr. Clemens Scheinecker

Klinische Abteilung für Rheumatologie, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien


1 Carvalheiras G, Faria R, Braga J, Vasconcelos C, Fetal outcome in autoimmune diseases. Autoimmun Rev 2012; 11(6–7): A520–530
2 Roopenian DC, Akilesh S, FcRn: the neonatal Fc receptor comes of age. Nat Rev Immunol 2007; 7 (9):715–725
3 Murashima A, Watanabe N, Ozawa N, Saito H, Yamaguchi K, Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant’s serum. Ann Rheum Dis 2009; 68 (11):1793–1794
4 Mahadevan U, Wolf DC, Dubinsky M et al., Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2013; 11 (3):286–292; quiz e224
5 Hunt JS, Chen HL, Miller L, Tumor necrosis factors: pivotal components of ­pregnancy? Biol Reprod. 1996; 54(3):554–562
6 Lau et al., Arthritis Rheum 2013; 65 (Suppl. 10): 2041
7 Ostensen M, Safety issues of biologics in pregnant patients with rheumatic diseases. Ann N Y Acad Sci 2014; 1317:32–38
8 Sheeran C, Nicolopoulos J, Pregnancy outcomes of two patients exposed to ustekinumab in the first trimester. Australas J Dermatol 2014; 55 (3):235–236
9 Ojeda-Uribe M, Afif N., Dahan E et al., Exposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseases. Clin Rheumatol 2013; 32 (5):695–700
10 Danve A, Perry L, Deodhar A, Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus – A case report. Semin Arthritis Rheum 2014

FdR 04|2014

Publikationsdatum: 2014-12-23